A Study of 2-dose Vaccine Regimen Using 3 Consecutive Lots of Ad26.ZEBOV and MVA-BN-Filo in Adult Participants

Condition:   Ebola Interventions:   Biological: Ad26.ZEBOV;   Biological: MVA-BN-Filo;   Biological: Placebo Sponsor:   Janssen Vaccines & Prevention B.V. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials